Navigation Links
New Blood Clot Removal System Successfully Restores Blood Flow
Date:7/25/2013

PARK CITY, Utah, July 25, 2013 /PRNewswire-iReach/ -- Dr. Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, Louisiana, used a new hand-held mechanical aspiration system to remove blood clots and increase blood flow.

(Photo: http://photos.prnewswire.com/prnh/20130725/MN53083)

The patented ASPIRE Aspirator connects to any aspiration catheter and aspirates, or sucks out, blood clots in blocked arteries and veins.  ASPIRE systems allow clinicians to instantly start, stop, increase, decrease, or pulse aspiration during a variety of procedures. 

During the procedure, which takes place in a catheterization laboratory, a small catheter is inserted into the patient's leg and is guided to the blocked vessel.  Once a catheter is in the vein or artery, the cardiologist can diagnose the location and extent of the lesion.  Treatment options vary depending on the age, size, and location of the blood clot.  Clinicians may follow blood clot aspiration with stent, bypass, or other intervention. 

"Most people know that blood clots are lethal in the heart and brain.  But, blood clots can be life-threatening in the legs, lung, and other organs too," said Dr. Cavros.  "Our CIS team has experience treating a wide range of blood clots with numerous tools.  We focus on the patient's needs and tailor the right therapy to improve care—fast."

Blood clot aspiration is typically performed with basic syringes or electromechanical pumps.  Basic syringes require two hands to operate, are volume limited, and do not maintain consistent aspiration force.  Electromechanical systems can aspirate more volume with increased force, but are expensive, can be difficult to use, r
'/>"/>

SOURCE Control Medical Technology
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
2. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
3. Global Blood Pressure Monitor Market 2012-2016: High Competition among Vendors Could Pose a Challenge to Growth of this Market
4. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
5. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
6. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
7. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
8. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
9. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
10. "Blood Therapy" Has Patients Flocking to Washington DCs Pioneering Pain Doctor
11. Inostics Blood-based Mutation Testing Receives CLIA Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Kan. , Aug. 21, 2014 /PRNewswire-iReach/ -- ... Trust Alliance (HITRUST) under its Common Security Framework ... Enterprise Security and Privacy Manager, "We appreciate this ... level of commitment that this certification signifies. Our ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s ...
(Date:8/21/2014)... YORK , August 21, 2014 ... Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license ... software for plant breeders and researchers, today is ... a joint venture with Seach Ltd, a leading ... formed to research and develop new breeds of ...
(Date:8/21/2014)... Aug. 21, 2014 InfinityQS International, Inc., ... Manufacturing Intelligence , today announces Infusion Chicago, its ... will be held Oct. 9-10, 2014, at the ... to showcase the necessity for implementing a quality ... Manufacturing Intelligence to gain insight into production processes. ...
Breaking Medicine Technology:ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2
... Therapeutics, Inc., a privately held biopharmaceutical company, today ... trials (REDUCE-1 and REDUCE-2) evaluating its lead investigational ... famotidine. The analysis, which was designed to ... anti-inflammatory drug (NSAID)-associated ulcers, was presented at the ...
... LAKES, N.J., Oct. 26 Executives for Medco Health ... present at the following investor conferences: , Timothy Wentworth, ... Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, ... in New York; , David B. Snow Jr., Medco ...
Cached Medicine Technology:Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 2Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 3Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 4Medco to Present at November 2009 Investor Conferences 2
(Date:8/22/2014)... somatic mutation at amino acid 918 in the RET ... cell lung cancer (SCLC) tumors and enforced expression of ... signaling and cell growth. , SCLC is a highly ... lung cancers and is strongly associated with tobacco smoking. ... examined for genomic alterations and targeted therapies are approved ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... Restore My Vision Today , ... Pearson to help people discover how they can get ... by instead improving their eyesight naturally has caught the ... , “There’s a reason why the glasses and contacts ... because people just assume that it’s their only option ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Testosterone ... filed in U.S. courts on behalf of men ... their use of prescription low testosterone therapies, Bernstein ... new claim was filed against Pfizer Inc. on ... suffered life-threatening heart issues due to his use ...
(Date:8/22/2014)... Wisconsin (PRWEB) August 22, 2014 Mueller ... for Plantar Fasciitis, an exciting new product that provides ... you to stay active while you heal. The package ... is truly a new technology – it is not ... , FasciaDerm® PFTape™ System for Plantar Fasciitis ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... - Transition Therapeutics Inc. ("Transition" or the "Company") ... the first patient has been dosed in a ... with a proprietary Lilly GLP-1 analogue, in patients ... randomized, double-blind, placebo-controlled study in approximately 140 patients ...
... Kan., March 23 According to the National Bureau ... since December 2007 and nearly half of U.S. residents ... Oprah Winfrey replaced her annual ,Favorite Things, holiday show ... Holiday Ever!"However, the $200 billion health & wellness industry ...
... best news that we have been waiting on for the ... through Sinus Dynamics.WESTLAKE VILLAGE, Calif., March 23 Most ENTs ... if it would be better to have a clinical study ... the sinuses. Now this fantastic news and clinical study proves ...
... an industry leader in transportation brokerage for medical and social ... telephony infrastructure. The upgrade will increase simultaneous call volume capability ... ... Louis, MO (PRWEB) March 23, 2009 - Medical Transportation ...
... quality urgent care, serving local Colorado communities from six immediate care ... ... 2009 -- Urgent care provider NextCare ( www.nextcare.com ) announces the ... new locations in Broomfield and Longmont now open and a location ...
... Johnson Foundation (RWJF) and the Plexus Institute (Plexus) today ... Staphylococcus aureus (MRSA) prevention program that employed ... behavioral change, to trigger significant reductions in MRSA incidence ... In addition, as MRSA rates dropped, the hospitals saw ...
Cached Medicine News:Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2Health News:Consumers Redefine Value in the Recession: Sauna Sales Prove Preventive Health Is an Essential Investment 2Health News:New Clinical Study News for Treatment of Sinusitis, Sinus Infection and Allergy Sufferers Now Have a New Effective Form of Relief through Sinus Dynamics 2Health News:MTM Upgrades its Phone System to Ensure Leading edge Technology and Software Feature sets for Existing and Future Clients 2Health News:Three New NextCare Immediate Care Clinic Locations Open in Colorado 2Health News:CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent 2Health News:CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent 3
... Powerful and Flexible Impact And Impact2 ... different volume ranges, our single channel Impact ... demands of any application. Engineered with the ... our multichannel line, these pipettors are equally ...
... Powerful and Flexible Impact And Impact2 Pipettors ... volume ranges, our single channel Impact and ... of any application. Engineered with the same ... multichannel line, these pipettors are equally easy ...
... is a major step forward in ... handling system - with one universal ... modules. All five single channel and ... one handle. The lightweight handle is ...
... solution and best value in high performance ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
Medicine Products: